Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

ICL-670 in beta-thalassemia and associated transfusional iron overload

Dec. 12, 2003

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Dec. 11, 2003

Potential use of SB-277011-A in preventing relapse to cocaine abuse

Nov. 28, 2003

Promising results for ferumoxytol in anemia and chronic kidney disease

Nov. 27, 2003

Britannia and US WorldMeds sign licensing agreement for lofexidine

Nov. 21, 2003

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Neramexane shows promise for the treatment of alcohol dependence

Nov. 18, 2003

TA-CD advances into phase IIb for cocaine addiction

Oct. 28, 2003

TA-NIC enters second phase I trial

Oct. 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...